X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33942) 33942
Publication (4847) 4847
Book Chapter (414) 414
Book Review (221) 221
Newsletter (170) 170
Dissertation (86) 86
Conference Proceeding (65) 65
Newspaper Article (22) 22
Government Document (9) 9
Magazine Article (9) 9
Data Set (7) 7
Reference (6) 6
Book / eBook (2) 2
Journal / eJournal (2) 2
Paper (2) 2
Trade Publication Article (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15550) 15550
immunology (15169) 15169
animals (15112) 15112
index medicus (14154) 14154
mice (11637) 11637
cd8 antigen (9896) 9896
lymphocytes (9681) 9681
female (8988) 8988
lymphocytes t (8401) 8401
t cells (7589) 7589
cd8-positive t-lymphocytes - immunology (7157) 7157
male (7099) 7099
cd8 t-cells (6288) 6288
cd4 antigen (5472) 5472
cd8 (5443) 5443
flow cytometry (4767) 4767
mice, inbred c57bl (4657) 4657
dendritic cells (4462) 4462
adult (4344) 4344
t-lymphocytes - immunology (4286) 4286
expression (4228) 4228
antigens (4028) 4028
middle aged (3894) 3894
cd4-positive t-lymphocytes - immunology (3751) 3751
immune response (3663) 3663
immunotherapy (3635) 3635
cancer (3464) 3464
cytokines (3387) 3387
immunity (3295) 3295
oncology (3271) 3271
research article (3175) 3175
immune system (3165) 3165
activation (2968) 2968
multidisciplinary sciences (2962) 2962
infection (2935) 2935
t-lymphocyte subsets - immunology (2915) 2915
cell biology (2870) 2870
in-vivo (2824) 2824
medicine (2725) 2725
research (2721) 2721
cytotoxicity (2715) 2715
inflammation (2691) 2691
lymphocyte activation (2668) 2668
infections (2664) 2664
health aspects (2662) 2662
infectious diseases (2652) 2652
article (2647) 2647
mice, inbred balb c (2628) 2628
cd4 (2580) 2580
analysis (2533) 2533
t-lymphocytes, cytotoxic - immunology (2487) 2487
apoptosis (2479) 2479
cells, cultured (2467) 2467
tumors (2441) 2441
t cell receptors (2423) 2423
aged (2384) 2384
science (2350) 2350
medicine, research & experimental (2336) 2336
vaccines (2325) 2325
proteins (2286) 2286
virology (2262) 2262
cd8 antigens - analysis (2257) 2257
viruses (2253) 2253
gene expression (2184) 2184
responses (2116) 2116
t-cells (2080) 2080
dendritic cells - immunology (1972) 1972
antigen (1950) 1950
cd8-positive t-lymphocytes - metabolism (1917) 1917
vaccination (1890) 1890
cd8 antigens (1882) 1882
mice, transgenic (1880) 1880
cd8 antigens - immunology (1803) 1803
cell proliferation (1787) 1787
differentiation (1765) 1765
mice, knockout (1760) 1760
microbiology (1728) 1728
biology (1672) 1672
hiv (1661) 1661
interferon (1636) 1636
cd4 antigens - analysis (1616) 1616
immunization (1595) 1595
cell activation (1557) 1557
immunohistochemistry (1549) 1549
major histocompatibility complex (1533) 1533
antigen presentation (1529) 1529
cells (1522) 1522
disease models, animal (1517) 1517
antibodies (1515) 1515
transplantation (1500) 1500
disease (1493) 1493
physiological aspects (1491) 1491
phenotype (1445) 1445
patients (1434) 1434
hiv infections - immunology (1426) 1426
macrophages (1405) 1405
medical research (1400) 1400
cd8 t cells (1383) 1383
hematology (1373) 1373
immunophenotyping (1369) 1369
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (33912) 33912
Chinese (202) 202
French (100) 100
Japanese (94) 94
Russian (61) 61
Polish (47) 47
German (38) 38
Korean (32) 32
Spanish (27) 27
Portuguese (9) 9
Czech (5) 5
Turkish (5) 5
Swedish (3) 3
Ukrainian (3) 3
Persian (2) 2
Bulgarian (1) 1
Danish (1) 1
Hungarian (1) 1
Italian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 07/2019, Volume 10, p. 1648
Background: Haplotype-specific alternative splicing of the endoplasmic reticulum (ER) aminopeptidase type 2 (ERAP2) gene results in either full-length (FL,... 
HIV-1 | CD8(+) | haplotype | PROTEIN | ERAP2 | IFN gamma | SUBSETS | IMMUNOLOGY | IDENTIFICATION | OXYTOCINASE SUBFAMILY | NATURAL-RESISTANCE | secretion | MDM | immune system | CD4(+) | CTL | ANTIGEN | Antiviral agents | Care and treatment | Usage | Messenger RNA | Analysis | Disease susceptibility | Research | HIV infection | HIV (Viruses) | Health aspects
Journal Article
Kasmera, ISSN 0075-5222, 2012, Volume 40, Issue 1, pp. 78 - 90
El papel de las celulas TCD4+ en la inmunidad contra la tuberculosis ha sido ampliamente estudiado. Sin embargo, la funcion de las celulas TCD8+ en la... 
Tuberculosis | Cytokines | Hiv | CD8+ T lymphocytes | Linfocitos CD8 | VIH (Viruses) | Investigacion inmunologica | Analisis | VIH | HIV | citocinas | cytokines | linfocitos T CD8
Journal Article
European Journal of Immunology, ISSN 0014-2980, 06/2019, Volume 49, Issue 6, pp. 966 - 968
It is a matter of current debate whether the bone marrow is a hub for circulating memory T lymphocytes and/or the home of resident memory T lymphocytes. Here... 
Spleen | Bone marrow | Tissue‐resident signature genes | Memory T cells | CD69 | Tissue-resident signature genes | Animal experimentation | Antigens | T cells | Gene expression | Analysis | Genes | Cell proliferation | CD69 antigen | Memory cells | Immunological memory | Lymphocytes | CD8 antigen | Lymphocytes T | CD4 antigen | Letter to the Editor
Journal Article
Nature Immunology, ISSN 1529-2908, 2013, Volume 14, Issue 3, pp. 281 - 289
Journal Article
Scientific Reports, ISSN 2045-2322, 02/2016, Volume 6, Issue 1, p. 20254
Tumor cell-derived exosomes (TEX) suppress functions of immune cells. Here, changes in the gene profiles of primary human T lymphocytes exposed in vitro to... 
MESSENGER-RNAS | CANCER-PATIENTS | EXTRACELLULAR VESICLES | MICROENVIRONMENT | MULTIDISCIPLINARY SCIENCES | MICROVESICLES | DIAGNOSTIC BIOMARKERS | INDUCE APOPTOSIS | OVARIAN-CANCER | MODULATION | LYMPHOCYTES | Exosomes - metabolism | Neoplasms - metabolism | CD8-Positive T-Lymphocytes - cytology | T-Lymphocytes, Regulatory - metabolism | T-Lymphocyte Subsets - cytology | Humans | Culture Media, Conditioned - pharmacology | RNA, Messenger - metabolism | Antigens, CD - metabolism | Lectins, C-Type - metabolism | T-Lymphocyte Subsets - drug effects | T-Lymphocytes, Regulatory - cytology | CD8-Positive T-Lymphocytes - metabolism | Real-Time Polymerase Chain Reaction | Microscopy, Electron, Transmission | CD4-Positive T-Lymphocytes - cytology | Apyrase - metabolism | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Antigens, Differentiation, T-Lymphocyte - metabolism | Down-Regulation - drug effects | Up-Regulation - drug effects | T-Lymphocytes, Regulatory - drug effects | T-Lymphocyte Subsets - metabolism | CD8-Positive T-Lymphocytes - drug effects | Adenosine - metabolism | Neoplasms - pathology | CD4-Positive T-Lymphocytes - drug effects | Microscopy, Fluorescence | Adenosine | Dendritic cells | CD8 antigen | Gene regulation | Data processing | T cell receptors | Lymphocytes T | Gene expression | Exosomes | Cell surface | CD4 antigen | Polymerase chain reaction | CD69 antigen | Cell activation | Lymphocytes | Down-regulation | Peripheral blood
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 4/2014, Volume 63, Issue 4, pp. 395 - 406
The programmed death-1 (PD-1) molecule is mainly expressed on functionally “exhausted” CD8+ T cells, dampening the host antitumor immune response. We evaluated... 
Immunology | Medicine & Public Health | Oncology | Cancer Research | Breast cancer | Immune evasion | Regulatory T cells | Cancer immunotherapy | PD-1 | APOPTOSIS | PROGNOSIS | TUMOR | RISK | ANTIBODY | IMMUNOLOGY | CHEMOTHERAPY | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | IMMUNOTHERAPY | CD8(+) T-LYMPHOCYTES | B7-H1 | Carcinoma, Lobular - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Programmed Cell Death 1 Receptor - analysis | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Antigens, Differentiation, T-Lymphocyte - analysis | Aged, 80 and over | Carcinoma, Ductal, Breast - pathology | Lymphocytes, Tumor-Infiltrating - chemistry | T-Lymphocytes, Regulatory - chemistry | Carcinoma, Lobular - immunology | CD8-Positive T-Lymphocytes - chemistry | Combined Modality Therapy | Carcinoma, Lobular - radiotherapy | T-Lymphocyte Subsets - pathology | Carcinoma, Ductal, Breast - radiotherapy | Forkhead Transcription Factors - analysis | Survival Analysis | CD8-Positive T-Lymphocytes - immunology | Lymphocytes, Tumor-Infiltrating - immunology | T-Lymphocyte Subsets - immunology | Breast Neoplasms - surgery | CD8-Positive T-Lymphocytes - pathology | Prognosis | Carcinoma, Ductal, Breast - immunology | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | T-Lymphocytes, Cytotoxic - pathology | T-Lymphocyte Subsets - chemistry | Mastectomy | Adult | Female | Radiotherapy, Adjuvant | T-Lymphocytes, Cytotoxic - immunology | Carcinoma, Ductal, Breast - surgery | Carcinoma, Lobular - surgery | Kaplan-Meier Estimate | Disease-Free Survival | Breast Neoplasms - radiotherapy | T-Lymphocytes, Cytotoxic - chemistry | Apoptosis - immunology | Lymphocytes, Tumor-Infiltrating - pathology | Breast Neoplasms - pathology | Lymphocyte Count | Breast Neoplasms - mortality | Aged
Journal Article
Journal Article
European Journal of Immunology, ISSN 0014-2980, 07/2016, Volume 46, Issue 7, pp. 1770 - 1782
We previously demonstrated an accumulation of tumor‐reactive CD4+CD8+ double positive (DP) T cells within melanoma‐infiltrating lymphocytes, supporting their... 
IL‐9R | IL‐9 | CD4+CD8+ double‐positive T lymphocyte | TIL | Melanoma | CD4 | IL-9R | CD8 | double-positive T lymphocyte | IL-9 | TH9 CELLS | CD8(+) | INDUCED APOPTOSIS | INTERLEUKIN-9 | RECEPTOR | PERIPHERAL-BLOOD | IMMUNOLOGY | CYTOKINE EXPRESSION | IN-VIVO | CD4(+) CD8(+) double-positive T lymphocyte | GROWTH-FACTOR | LYMPHOCYTES | T-Lymphocyte Subsets - immunology | Apoptosis - drug effects | Humans | CD4-Positive T-Lymphocytes - immunology | Lymphocyte Activation - immunology | Interleukin-9 - pharmacology | Melanoma - genetics | T-Lymphocyte Subsets - drug effects | CD8-Positive T-Lymphocytes - metabolism | Lymphocytes, Tumor-Infiltrating - metabolism | Cytotoxicity, Immunologic - drug effects | Melanoma - metabolism | Receptors, Interleukin-9 - metabolism | Gene Expression | Cytokines - metabolism | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Lymphocytes, Tumor-Infiltrating - drug effects | Melanoma - pathology | Cell Survival - immunology | Apoptosis - immunology | Receptors, Interleukin-9 - genetics | Lymphocyte Activation - drug effects | Melanoma - immunology | T-Lymphocyte Subsets - metabolism | CD8-Positive T-Lymphocytes - drug effects | CD8-Positive T-Lymphocytes - immunology | Interleukin-9 - immunology | CD4-Positive T-Lymphocytes - drug effects | Lymphocytes, Tumor-Infiltrating - immunology | Parrots | T cells | Tumors | Life Sciences | Cancer
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2017, Volume 178, Issue 2, pp. 292 - 301
Journal Article
Journal Article
Journal Article